Author/Creator: Ye, Longyun - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Ye, Longyun

1. A critical role for c‐Myc in group 2 innate lymphoid cell activation. Issue 4 (29th January 2020)

Authors:: Ye, Longyun; Pan, Jiexue; Liang, Mingwei; Pasha, Muhammad Asghar; Shen, Xiaofei; D'Souza, Shanti S.; Fung, Ivan Ting Hin; Wang, Yinna; Patel, Gargi; Tang, Dale D.; Yang, Qi
Journal:: Allergy
Issue:: Volume 75:Issue 4(2020)
Page Start:: 841
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Blockade of IL‐4Rα inhibits group 2 innate lymphoid cell responses in asthma patients. Issue 2 (5th November 2019)

Authors:: Patel, Gargi; Pan, Jiexue; Ye, Longyun; Shen, Xiaofei; Rosloff, Daniel; D'Souza, Shanti S.; Fung, Ivan Ting Hin; Celstin, Jocylen; Sun, Wei; Sankar, Poornima; Zhang, Yuanyue; Pasha, Muhammad Asghar; Yang, Qi
Journal:: Clinical & experimental allergy
Issue:: Volume 50:Issue 2(2020)
Page Start:: 267
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Compartmentalized effects of aging on group 2 innate lymphoid cell development and function. Issue 6 (20th August 2019)

Authors:: D'Souza, Shanti S.; Shen, Xiaofei; Fung, Ivan T. H.; Ye, Longyun; Kuentzel, Marcy; Chittur, Sridar V.; Furuya, Yoichi; Siebel, Christian W.; Maillard, Ivan P.; Metzger, Dennis W.; Yang, Qi
Journal:: Aging cell
Issue:: Volume 18:Issue 6(2019)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Group‐2 Innate Lymphoid Cells Promote HCC Progression Through CXCL2‐Neutrophil‐Induced Immunosuppression. Issue 5 (4th October 2021)

Authors:: Xu, Xingyuan; Ye, Longyun; Zhang, Qi; Shen, Hang; Li, Shanshan; Zhang, Xiaoyu; Ye, Mao; Liang, Tingbo
Journal:: Hepatology
Issue:: Volume 74:Issue 5(2021)
Page Start:: 2526
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. The optimal duration of capecitabine plus temozolomide in patients with well‐differentiated pancreatic NETs with or without maintenance therapy. (5th April 2022)

Authors:: Gao, Heli; Dong, Jia; Zhang, Wuhu; Xu, Huaxiang; Ye, Longyun; Li, Hao; Wang, Wenquan; Liu, Liang; Yu, Xianjun
Journal:: Journal of neuroendocrinology
Issue:: Volume 34:Number 6(2022)
Page Start:: n/a
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. The prognostic value of sarcopenia combined with preoperative fibrinogen–albumin ratio in patients with intrahepatic cholangiocarcinoma after surgery: A multicenter, prospective study. (8th June 2021)

Authors:: Yu, Haitao; Wang, Mingxun; Wang, Yi; Yang, Jinhuan; Deng, Liming; Bao, Wenming; He, Bangjie; Lin, Zixia; Chen, Ziyan; Chen, Kaiyu; Zhang, Baofu; Liu, Fangting; Yu, Zhengping; Ye, Longyun; Jin, Bin; Chen, Gang
Journal:: Cancer medicine
Issue:: Volume 10:Number 14(2021)
Page Start:: 4768
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Tissue‐resident CXCR4+ macrophage as a poor prognosis signature promotes pancreatic ductal adenocarcinoma progression. Issue 11 (21st February 2023)

Authors:: Liao, Zhenyu; Ye, Longyun; Li, Tianjiao; Jin, Xing; Lin, Xuan; Fei, Qinglin; Zhang, Huiru; Shi, Saimeng; Yu, Xianjun; Jin, Kaizhou; Wu, Weiding
Journal:: International journal of cancer
Issue:: Volume 152:Issue 11(2023)
Page Start:: 2396
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗